期刊文献+

COPD患者膜弥散和肺血管床容量的变化及支气管扩张剂的影响

Changes of membrane diffusing capacity and pulmonary capillary blood volume in chronic obstructive pulmonary disease patients of different stages and after bronchodilator inhalation
下载PDF
导出
摘要 目的:探索慢性阻塞性肺疾病(COPD)缓解期不同分级的患者膜弥散功能(Dm)和肺血管床容量(Vc)的变化,以及使用支气管扩张剂后通气功能改善对Dm和Vc的影响。方法:2001年7月至2004年2月COPD缓解期患者95例,分为4组,Ⅰ级8例,Ⅱ级47例,Ⅲ级34例,Ⅳ级6例,正常对照组35例。使用一口气法,测定弥散量(DLCO)、弥散率(KCO即DLCO/VA)、Dm、Vc。58例COPD患者予以做扩张试验,试验阳性和阴性者均再次测定DLCO、KCO、Dm、Vc。将各组间的测定值及扩张前后的结果进行比较。结果:COPD各组患者的Dm、DLCO、Vc及KCO均低于正常对照组,随着级别的增加,降低的程度均加大。COPDⅠ级患者的Vc和KCO显著低于对照组(P<0.05,P<0.01),COPDⅡ级、Ⅲ级及Ⅳ级患者的DLCO、KCO、Dm、Vc均显著低于对照组(P<0.01)。COPD各分级之间除Vc没有显著的差别(P>0.05)外,Dm、DLCO和KCO差异均有显著性(P<0.01)。支气管扩张试验阳性患者扩张试验前后的DLCO、Dm、Vc均无显著的改变(P>0.05)。结论:COPD患者通气功能逐渐恶化导致了弥散量的下降,Dm的持续降低贯穿于整个COPD的早、中、晚期,而Vc的持续下降则发生在COPD的早、中期。支气管扩张剂的使用没有通过通气/血流比的改变对弥散量、Dm、Vc产生影响。 Objective: To assess the changes of the membrane diffusing capacity (Dm) and pulmonary capillary blood volume (Vc) in different stages of COPD and the effect of the bronchodilator inhalation on diffusing capacity (DLCO) and Dm in COPD patients. Method:95 stable COPD patients have been classified into 4 groups: Stage Ⅰ,Ⅱ,Ⅲ and Ⅳ according to EFV1/FVC%, FEV1 % values, each with 8, 47, 34, 6 patients respectively. Diffusing capacity ( DLCO), KCO ( DLCO/V, ), Dm and Vc were measured in baseline and after bronchodilator inhalation test with single breathing method. Result:In stage Ⅰ group, Dm, Vc, DLCO and KCO are all lower than normal subject group, but only Vc and KCO have reached significance ( P 〈 0.05, P 〈 0.01 ). DLCO, KCO, Dm are progressively decreased from Stage Ⅰ group to Stage Ⅳ group, all these parameters are significantly lower in stage Ⅱ,Ⅲ,Ⅳ groups comparing with that of normal subject group ( P 〈 0.01 ). Vc are also gradually decreased from stage Ⅰ group to Stage Ⅲ group, but not further decreased in Stage Ⅳ group, the value in this group is comparable with that of Stage Ⅰ , Ⅱ and Ⅲ (P 〉 0.05). No significant changes have been found in DLCO, Din, and Vc after bronchodilator inhalation in Stage Ⅰ to Ⅲ groups. Conclusion: Dm is progressively reduced with the severity of COPD, but the same trend of Vc reduction discontinues further in stage Ⅳ . Bronchodilator inhalation does not affect DLCO, Din, and Vc.
出处 《心肺血管病杂志》 CAS 2007年第1期7-10,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 慢性阻塞性肺疾病 膜弥散 肺血管床容量 Chronic obstructive pulmonary disease Membrane diffusing capacity Pulmonary capillaryVolume
  • 相关文献

参考文献8

  • 1薛全福.病理生理和发病机制//翁心植.慢性阻塞性肺疾病与肺原性心脏病.北京:北京出版社,1998:29-64.
  • 2茌璐琪,刘又宁,朴哲龙,郝峰英,张青勉.慢性阻塞性肺疾病和结缔组织病患者膜弥散与肺血管床容量的分析[J].中华结核和呼吸杂志,1998,21(6):344-347. 被引量:8
  • 3Xie C, Rong Z, Li Z, et al. Measurements of membrane diffusing capacity and pulmonary capillary blood volume in normal subjects and patients with mild emphysema. Chin Med J(Engl) , 1996,109 : 840-847.
  • 4Zanen P, Van der Lee L,Van der Mark T, et al. Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume. Eur Respir J, 2001,18:764-769.
  • 5Chou KC, Chang SC, Chang HI, et al. Body position,membrane diffuing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema.Zhonghua Yi Xue Za Zhi (Taipei), 1999, 62:209-216.
  • 6Global initiative for chronic obstructive lung disease(Gold). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease updated. 2005, P6-9, P28-43.
  • 7Morrison NJ, Abboud RT, Muller NL, et al. Pulmonary capillary blood volume in emphysema. Am Rev Respir Dis,1990, 141:53-61.
  • 8Frans A, Stanescu DC, Veriter C, et al. Smoking and pulmonary diffusing capacity. Scand J Respir Dis, 1975 ,56:165-183.

二级参考文献2

  • 1施守义,风湿病学.下,1995年,1063页
  • 2施守义,风湿病学.下,1995年,1083页

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部